A detailed history of Rhumbline Advisers transactions in Olink Holding Ab (Publ) stock. As of the latest transaction made, Rhumbline Advisers holds 2,340 shares of OLK stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,340
Previous 2,079 12.55%
Holding current value
$0
Previous $48,000 22.92%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$21.87 - $25.59 $5,708 - $6,678
261 Added 12.55%
2,340 $59,000
Q1 2024

May 09, 2024

BUY
$21.81 - $25.14 $6,237 - $7,190
286 Added 15.95%
2,079 $48,000
Q4 2023

Feb 08, 2024

BUY
$14.29 - $25.95 $6,501 - $11,807
455 Added 34.01%
1,793 $45,000
Q3 2023

Nov 09, 2023

BUY
$14.45 - $20.34 $144 - $203
10 Added 0.75%
1,338 $19,000
Q2 2023

Aug 08, 2023

BUY
$17.13 - $23.74 $22,748 - $31,526
1,328 New
1,328 $24,000

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.